PAPERS TO WATCH

Credit: © ERWIN SIGEL" /> Credit: © ERWIN SIGEL >> Settling an oocyte actin conundrumActin is actively cleared from the nuclei of most eukaryotic cells with the exception of the giant nuclei found in amphibian oocytes. This discrepancy has led to speculations about exotic actin conformations serving equally exotic functions in specialized nuclei. Dirk Görlich of the Center for Molecular Biology at Heidelberg University and his group recently reported that the mechanism for having

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

>> Settling an oocyte actin conundrum

Actin is actively cleared from the nuclei of most eukaryotic cells with the exception of the giant nuclei found in amphibian oocytes. This discrepancy has led to speculations about exotic actin conformations serving equally exotic functions in specialized nuclei. Dirk Görlich of the Center for Molecular Biology at Heidelberg University and his group recently reported that the mechanism for having actin in these oocyte nuclei is actually quite simple.1 Exp6, an actin specific exporter conserved from amoeba to vertebrate, is absent from the amphibian oocyte. Adding Exp6 to oocytes from Xenopus laevis cleared the actin and resulted in fragile giant nuclei, consistent with a structural role from an F-actin scaffold. Duke University professor and Faculty of 1000 member Harold Erickson calls the study "simply beautiful."

"I've found the idea of whether there's actin in the nucleus to be interesting over time. And usually reports ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies